Among 13 analysts covering Teradata Corporation (NYSE:TDC), 1 have Buy rating, 7 Sell and 5 Hold. Therefore 8% are positive. Teradata Corporation had 25 analyst reports since August 7, 2015 according to SRatingsIntel. On Friday, February 10 the stock rating was downgraded by Mizuho to “Underperform”. RBC Capital Markets maintained the shares of TDC in report on Friday, February 5 with “Sector Perform” rating. As per Friday, August 28, the company rating was downgraded by Atlantic Securities. The rating was upgraded by Monness Crespi & Hardt on Friday, August 7 to “Neutral”. The company was maintained on Friday, November 6 by Mizuho. The stock has “Sell” rating by Goldman Sachs on Friday, December 11. On Friday, June 24 the stock rating was initiated by Cowen & Co with “Market Perform”. The rating was downgraded by Susquehanna to “Neutral” on Friday, August 7. The firm has “Neutral” rating by Mizuho given on Friday, August 7. RBC Capital Markets maintained Teradata Corporation (NYSE:TDC) rating on Friday, August 7. RBC Capital Markets has “Sector Perform” rating and $33 target. See Teradata Corporation (NYSE:TDC) latest ratings:
10/02/2017 Broker: Mizuho Old Rating: Neutral New Rating: Underperform Downgrade
10/02/2017 Broker: BMO Capital Markets Rating: Market Perform Old Target: $27 New Target: $32 Maintain
11/01/2017 Broker: Wells Fargo Rating: Underperform Initiate
The stock of Accelerate Diagnostics Inc (NASDAQ:AXDX) is a huge mover today! About 87,938 shares traded. Accelerate Diagnostics Inc (NASDAQ:AXDX) has declined 0.55% since September 13, 2016 and is downtrending. It has underperformed by 10.48% the S&P500.The move comes after 7 months negative chart setup for the $1.39 billion company. It was reported on Apr, 20 by Barchart.com. We have $23.70 PT which if reached, will make NASDAQ:AXDX worth $69.50 million less.
Teradata Corporation is a provider of analytic data platforms, analytic applications and related services. The company has market cap of $4.24 billion. The Company’s divisions include Americas region and International region (Europe, Middle East, Africa, Asia Pacific and Japan). It has a 33.98 P/E ratio. The Company’s offerings include analytics solutions, ecosystem architecture consulting and hybrid cloud solutions.
Since December 1, 2016, it had 0 buys, and 6 insider sales for $1.59 million activity. 11,681 shares were sold by Harrington Daniel L, worth $327,068. Ratzesberger Oliver sold $114,022 worth of stock or 4,192 shares. Another trade for 10,044 shares valued at $273,749 was sold by FU CARY T. Another trade for 860 shares valued at $26,700 was made by COOPER NANCY E on Thursday, February 16. The insider Nyquist Laura K sold 23,892 shares worth $741,120.
Investors sentiment decreased to 0.73 in Q4 2016. Its down 0.50, from 1.23 in 2016Q3. It dived, as 57 investors sold Teradata Corporation shares while 121 reduced holdings. 44 funds opened positions while 86 raised stakes. 135.15 million shares or 2.81% more from 131.46 million shares in 2016Q3 were reported. Massachusetts-based Adage Prns Gru Ltd Liability has invested 0.01% in Teradata Corporation (NYSE:TDC). 20,936 were reported by Pictet Asset Mgmt Limited. Guggenheim Ltd has invested 0.14% in Teradata Corporation (NYSE:TDC). Country Trust Bankshares has invested 0% of its portfolio in Teradata Corporation (NYSE:TDC). Glenmede Trust Na has invested 0.07% in Teradata Corporation (NYSE:TDC). Panagora Asset Mgmt Inc holds 1.08 million shares. Parametric Portfolio Limited Com reported 0.02% in Teradata Corporation (NYSE:TDC). Mutual Of America Ltd Llc invested in 16,184 shares or 0.01% of the stock. Focused Wealth Management reported 76 shares. Exxonmobil Invest Management Tx has 30,068 shares for 0.02% of their portfolio. X Mngmt Co Ltd Llc owns 8,691 shares or 0.01% of their US portfolio. 2,442 are held by Victory Mgmt. Great West Life Assurance Can invested in 34,104 shares or 0% of the stock. Northwestern Mutual Wealth Mgmt Comm holds 1,925 shares or 0% of its portfolio. Patten Gp Incorporated holds 0% or 36 shares.
About 1.04M shares traded. Teradata Corporation (NYSE:TDC) has risen 6.31% since September 13, 2016 and is uptrending. It has underperformed by 3.61% the S&P500.
Analysts await Accelerate Diagnostics Inc (NASDAQ:AXDX) to report earnings on May, 9. They expect $-0.33 earnings per share, down 13.79% or $0.04 from last year’s $-0.29 per share. After $-0.31 actual earnings per share reported by Accelerate Diagnostics Inc for the previous quarter, Wall Street now forecasts 6.45% negative EPS growth.
Investors sentiment increased to 1.69 in Q4 2016. Its up 0.66, from 1.03 in 2016Q3. It increased, as 10 investors sold Accelerate Diagnostics Inc shares while 19 reduced holdings. 11 funds opened positions while 38 raised stakes. 14.32 million shares or 5.44% more from 13.58 million shares in 2016Q3 were reported. 118,988 were reported by Fincl Bank Of New York Mellon. First Advsrs L P invested in 0% or 80,112 shares. Driehaus Capital Mngmt Ltd Liability Company holds 0.03% of its portfolio in Accelerate Diagnostics Inc (NASDAQ:AXDX) for 39,910 shares. Wells Fargo And Mn invested 0% in Accelerate Diagnostics Inc (NASDAQ:AXDX). Aqr Capital Mngmt Limited Com holds 0% or 15,832 shares in its portfolio. Cutter & Comm Brokerage invested in 27,885 shares or 0.24% of the stock. Fairfield Bush & Commerce reported 10,990 shares stake. Legal And General Plc owns 5,108 shares for 0% of their portfolio. Tower Research Cap Llc (Trc) invested 0% of its portfolio in Accelerate Diagnostics Inc (NASDAQ:AXDX). Iguana Ltd Liability Company reported 30,000 shares. Invesco Limited has 0% invested in Accelerate Diagnostics Inc (NASDAQ:AXDX). State Street Corporation has invested 0% in Accelerate Diagnostics Inc (NASDAQ:AXDX). Geode Cap Management Limited Liability Company accumulated 217,569 shares or 0% of the stock. First Republic Inv Mngmt reported 0.13% of its portfolio in Accelerate Diagnostics Inc (NASDAQ:AXDX). Art Advsrs Ltd Liability Company accumulated 19,800 shares.
Among 4 analysts covering Accelerate Diagnostics (NASDAQ:AXDX), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Accelerate Diagnostics had 5 analyst reports since August 25, 2015 according to SRatingsIntel. On Tuesday, August 9 the stock rating was maintained by JP Morgan with “Overweight”. The rating was initiated by Piper Jaffray with “Overweight” on Wednesday, December 16. The stock of Accelerate Diagnostics Inc (NASDAQ:AXDX) has “Neutral” rating given on Tuesday, August 25 by BTIG Research. JP Morgan initiated Accelerate Diagnostics Inc (NASDAQ:AXDX) rating on Thursday, March 24. JP Morgan has “Overweight” rating and $17 target. The firm earned “Outperform” rating on Friday, January 8 by William Blair.
Accelerate Diagnostics, Inc. is an in vitro diagnostics firm engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The company has market cap of $1.39 billion. The Company’s in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify , infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It currently has negative earnings. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results.
Since January 9, 2017, it had 3 insider purchases, and 1 insider sale for $ activity. Another trade for 8,000 shares valued at $152,000 was made by Strobeck Matthew on Monday, January 9. Another trade for 400,068 shares valued at $7.60 million was sold by Mehren Lawrence. Another trade for 339,368 shares valued at $6.45 million was bought by SCHULER JACK W. PATIENCE JOHN bought 52,700 shares worth $1.00 million.
